Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eniluracil DPD Activity in Colorectal Cancer
NCT00004195Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Sep 1998
- Primary completion
- Oct 1999
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in colorectal cancer (CRC) comparing Oral eniluracil with Placebo (2 arms). Primary endpoint: Enzymatic activity of dihydropyrimidine dehydrogenase (DPD) at Day 0. Started Sep 1998; status: completed.
02
Drugs
eniluracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00004195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004195.